Production of human t-cell leukemia (lymphotropic) retrovirus (htlv-i) envelope protein fragments in bacteria and use in seroepidemiological survey of human lymphoid malignancies
CA 1340878 C · Owner: Samuel, Kenneth · Inventors: Papas, Takis S.; Samuel, Kenneth; Wong-Staal, Flossie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Two regions of the gene for the HTLV-I envelope were expressed in Escherichia coli by use of the vector pJLAl6. One corresonds to the carboxy-terminal region of the major envelope protein p46 and the other corresponds to the transmembrane protein p2lE. Reactivity of the expressed protein with human sera was tested by Western blot procedure. Each of the sera tested that had been shown to contain anti-HTLV-I or anti-HTLV-II antibodies by ELISA assay recognized the bacterially synthesized envelope proteins. There was no reaction detected when control sera. were tested. This system is useful for large scale seroepidemiological surveys for this and related human retroviruses.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted January 25, 2000. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended January 25, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.